How do genetic variants affect our interpretation of non-invasive tests for non-alcoholic fatty liver disease?
- PMID: 32537755
- DOI: 10.1111/jgh.15124
How do genetic variants affect our interpretation of non-invasive tests for non-alcoholic fatty liver disease?
Similar articles
-
Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease.Liver Int. 2019 Mar;39(3):540-556. doi: 10.1111/liv.14006. Epub 2018 Dec 21. Liver Int. 2019. PMID: 30444569
-
Disease progression: Divergent paths.Nature. 2017 Nov 23;551(7681). doi: 10.1038/d41586-017-06925-2. Nature. 2017. PMID: 29168825 No abstract available.
-
Metabolic liver disease - what's in a name?Nat Rev Endocrinol. 2021 Feb;17(2):79-80. doi: 10.1038/s41574-020-00452-3. Nat Rev Endocrinol. 2021. PMID: 33257823 Review. No abstract available.
-
Apolipoprotein B and PNPLA3 Double Heterozygosity in a Father-Son Pair With Advanced Nonalcoholic Fatty Liver Disease.Hepatology. 2020 Jan;71(1):383-385. doi: 10.1002/hep.30874. Epub 2019 Oct 10. Hepatology. 2020. PMID: 31343751 No abstract available.
-
PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.World J Gastroenterol. 2015 Jan 21;21(3):794-802. doi: 10.3748/wjg.v21.i3.794. World J Gastroenterol. 2015. PMID: 25624712 Free PMC article. Review.
References
-
- Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 2019; 156: 1264, e1264-1281.
-
- Wong VW, Adams LA, de Ledinghen V, Wong GL, Sookoian S. Noninvasive biomarkers in NAFLD and NASH-current progress and future promise. Nat. Rev. Gastroenterol. Hepatol. 2018; 15: 461-478.
-
- Romeo S, Kozlitina J, Xing C et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 2008; 40: 1461-1465.
-
- Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J. Hepatol. 2017; 67: 862-873.
-
- Liu WY, Zheng KI, Pan XY et al. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2020; 35: 1057-1064.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical